Blockchain Registration Transaction Record

AGC Biologics Appoints Alberto Santagostino as New CEO

AGC Biologics appoints Alberto Santagostino as the new CEO, signaling a new chapter for the company and its commitment to delivering reliable and expert services to the biopharmaceutical industry.

AGC Biologics Appoints Alberto Santagostino as New CEO

This news matters as it signals a new chapter for AGC Biologics and its commitment to delivering reliable and expert services to the biopharmaceutical industry. Alberto's appointment is expected to enhance the company's reputation and solidify its position as a top CDMO service provider, impacting the industry as a whole.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x79d2a7a8b9c9951b2905fed7425d442dbc0417a5e2ef41b51ad1579fc5ca0ddc
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintdualsqSC-cf2a25d9090414c788ae1e82cf08a31f